Citius Pharmaceuticals Inc (CTXR)
0.3454
-0.01
(-3.76%)
USD |
NASDAQ |
Nov 04, 16:00
0.346
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Free Cash Flow: -29.09M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -29.09M |
| March 31, 2024 | -30.30M |
| December 31, 2023 | -30.37M |
| September 30, 2023 | -29.06M |
| June 30, 2023 | -28.59M |
| March 31, 2023 | -26.72M |
| December 31, 2022 | -28.53M |
| September 30, 2022 | -28.36M |
| June 30, 2022 | -27.62M |
| March 31, 2022 | -24.73M |
| December 31, 2021 | -19.34M |
| September 30, 2021 | -64.26M |
| June 30, 2021 | -22.02M |
| March 31, 2021 | -21.19M |
| December 31, 2020 | -21.38M |
| September 30, 2020 | -16.93M |
| June 30, 2020 | -16.48M |
| March 31, 2020 | -16.01M |
| December 31, 2019 | -15.39M |
| September 30, 2019 | -12.44M |
| June 30, 2019 | -12.04M |
| March 31, 2019 | -10.76M |
| December 31, 2018 | -11.04M |
| September 30, 2018 | -11.32M |
| June 30, 2018 | -12.24M |
| Date | Value |
|---|---|
| March 31, 2018 | -12.40M |
| December 31, 2017 | -9.098M |
| September 30, 2017 | -7.971M |
| June 30, 2017 | -6.309M |
| March 31, 2017 | -6.468M |
| December 31, 2016 | -6.518M |
| September 30, 2016 | -5.900M |
| June 30, 2016 | -4.839M |
| March 31, 2016 | -2.905M |
| December 31, 2015 | -2.348M |
| September 30, 2015 | -2.385M |
| June 30, 2015 | -1.729M |
| March 31, 2015 | -1.133M |
| December 31, 2014 | -1.338M |
| June 30, 2014 | -0.6102M |
| March 31, 2014 | -0.565M |
| December 31, 2013 | -0.5422M |
| September 30, 2013 | -0.0206M |
| June 30, 2013 | -0.0187M |
| March 31, 2013 | -0.0214M |
| December 31, 2012 | -0.0184M |
| September 30, 2012 | -0.0203M |
| June 30, 2012 | -0.0198M |
| March 31, 2012 | -0.019M |
| December 31, 2011 | -0.0199M |
Free Cash Flow Range, Past 5 Years
-64.26M
Minimum
Sep 2021
-15.39M
Maximum
Dec 2019
-26.13M
Average
-26.72M
Median
Mar 2023
Free Cash Flow Benchmarks
| Agilent Technologies Inc | 1.417B |
| Seelos Therapeutics Inc | -13.27M |
| Cara Therapeutics Inc | -83.33M |
| Moleculin Biotech Inc | -25.75M |
| Citius Oncology Inc | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.367M |
| Cash from Financing (Quarterly) | 13.72M |
| Free Cash Flow Per Share (Quarterly) | -0.0481 |
| Free Cash Flow Yield | -51.76% |